Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

The Role of Brain Penetrant BTK Inhibitors to Improve Outcomes in Patients with Multiple Sclerosis

Program Overview

This CME/CE program is derived from content presented at the 2021 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC). The expert faculty, led by Fred D. Lublin, MD, will highlight the important emerging role of Bruton's tyrosine kinase (BTK) inhibitors as the first brain penetrant disease modifying therapy that offers opportunities to improve neuroinflammation and neurodegeneration ...
View Course
The Conundrum of Managing Chronic Coronary Disease: DPI or DAPT?

Program Overview

This CME program is derived from content presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2021 Conference. Long-term protection from thrombotic/ischemic complications in patients with chronic coronary disease is an increasingly important topic given the aging of the population and the improved survival rates after an acute coronary syndrome (ACS). There are emerging data that support both dual antiplatelet ...
View Course
Updates in Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack

Program Overview

This CME/CNE activity will highlight updates in secondary prevention of ischemic stroke and transient ischemic attack. The expert faculty, Dr. Stephan Mayer, will first delve into the pathophysiology and disease burden of early recurrent ischemic neurovascular events. Next, Dr. Mayer will review the importance of antiplatelet therapy with both ASA and P2Y12 inhibitors in acute and early secondary ...
View Course
Update on the Long-Term Applications of Amikacin-Based Inhalation Therapeutics for the Treatment of Non-Tuberculous Mycobacterial Lung Disease

Program Overview

This CME program is derived from content presented at the Eastern Pulmonary Conference Annual Meeting. The expert faculty, Dr. Anne E. O’Donnell, will first highlight the pathophysiology, prevalence, and high-risk subgroups of non-tuberculous mycobacterial lung disease (NTM-LD). Following, Dr. O’Donnell will analyze current strategies for determining immunocompetent hosts and detecting radiographic manifestations in NTM-LD. The clinical implications of ...
View Course
Clinical Update for Systemic Sclerosing Interstitial Lung Disease

Program Overview

This CME/CE program is derived from content presented as part of a larger rheumatology state meeting lecture series. The expert faculty, Dr. Dinesh Khanna, will first discuss the history of systemic sclerosis-associated interstitial lung disease, including prevalence, predictors of progressive ILD and screening. Following, recent clinical trial data in the interstitial lung disease treatment landscape will be reviewed, ...
View Course
Advances in Fumarate-based Therapeutics to Improve Outcomes in Patients with Multiple Sclerosis

Program Overview

This CME/CE webcast, chaired by Fred D. Lublin, MD, will analyze current best practices for utilizing fumarate-based therapeutics to improve outcomes in patients with multiple sclerosis (MS). The expert faculty will first review the mechanism of action and targets of fumarates in the MS treatment landscape. Following, current trial data of fumarate-based therapeutics in MS will be reviewed ...
View Course

Upcoming Events

2021 ASHP Midyear Clinical Meeting and Exhibition

December 5th – 9th, 2021

The Alliance 2022 Annual Conference

January 12th – 15th, 2022

Maui Derm for Dermatologists 2022

January 24th – 28th, 2022

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022